Khavinson-class short peptide aimed at cartilage and joint health.
Typical dose range: 1–2 mg
Frequency: Daily
Route: Subcutaneous
Half-life: Short
Evidence level: Russian clinical (limited)
Part of the Khavinson bioregulator family. Western data is sparse, but it has a small loyal user base for chronic joint complaints.